Patent Assignment
Reel/Frame 028917/0475
Merger
Recorded: 2012-09-06
Pages: 5
Assignor
SOLSTICE NEUROSCIENCES, INC.
Executed: 2010-08-06
Assignee
SOLSTICE NEUROSCIENCES, LLC
40 GENERAL WARREN BLVD., SUITE 160, MALVERN, PENNSYLVANIA, 19355
Covered Properties
(8)
Method for treating dystonia with botulinum toxin type b
Patent:
6,290,961 →
Application:
09/490,756 →
Method for Treating Tardive Dyskinesia with Botulinum Toxin Type B
Method for Treating Neuromuscular Disorders and Conditions with Botulinum Toxin Types a and B
Method for Treating Essential Tremor with Botulinum Toxin Type B
Method for Treating Pain with Botulinum Toxin Type B
Method for Treating Cervical Dystonia with Botulinum Toxin Type B
Method and Compositions for the Treatment of Cerebral Palsy
Method for Treating Muscle Spasm with Botulinum Toxin Type B
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Mar 6, 2007
From: SOLSTICE NEUROSCIENCES, INC.
To: NEXBANK, SSB
Reel/Frame 018969/0513 →
Release and Reassignment
Aug 10, 2010
From: NEXBANK, SSB
To: SOLSTICE NEUROSCIENCES, INC.
Reel/Frame 024812/0653 →
Security Agreement
Sep 26, 2012
From: SOLSTICE NEUROSCIENCES, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 029041/0720 →
Release of Security Interest
Oct 14, 2014
From: JPMORGAN CHASE BANK, N.A.
To: SOLSTICE NEUROSCIENCES, LLC
Reel/Frame 033987/0440 →
Notice of Release of Security Interest
Nov 30, 2015
From: JPMORGAN CHASE BANK, N.A.
To: SOLSTICE NEUROSCIENCES, LLC
Reel/Frame 037171/0795 →